ACUMEN PHARMACEUTICALS INC (ABOS) — institutional ownership

101 funds reported holding ACUMEN PHARMACEUTICALS INC in their latest 13F filings, worth $132M in total (CUSIP 00509G209).

Largest holders

1. RA CAPITAL MANAGEMENT, L.P. — $56.1M
2. Sands Capital Alternatives, LLC — $9.93M
3. BlackRock, Inc. (BLK) — $6.65M
4. Alyeska Investment Group, L.P. — $6.55M
5. FRANKLIN RESOURCES INC (BEN) — $6.15M
6. ADAR1 Capital Management, LLC — $5.64M
7. VANGUARD CAPITAL MANAGEMENT LLC — $4.46M
8. Knollwood Investment Advisory, LLC — $4.35M
9. VANGUARD GROUP INC — $3.49M
10. GEODE CAPITAL MANAGEMENT, LLC — $3.05M

Famous investors holding it

• Renaissance Technologies portfolio (Renaissance Technologies)
• Two Sigma portfolio (Two Sigma Investments)
• Izzy Englander portfolio (Millennium Management)
• Ken Griffin portfolio (Citadel Advisors)

Insider buying and selling at ACUMEN PHARMACEUTICALS INC

Who owns the most ABOS stock?

The largest institutional holders in the latest 13F filings are RA CAPITAL MANAGEMENT, L.P. ($56.1M), Sands Capital Alternatives, LLC ($9.93M), BlackRock, Inc. (BLK) ($6.65M).

How many funds own ABOS?

101 funds reported holding it, worth $132M in total.